Showing results (11-20 of 550) with videos related to
Sort By:
Pageof 55
American Journal of Translational Research|December 8, 2009
Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa BYao Dai, Theodore S Lawrence, Liang XuSeminars in Radiation Oncology|October 3, 2006
The clinical application of intensity-modulated radiation therapyRandall K Ten Haken, Theodore S LawrenceSeminars in Radiation Oncology|June 9, 2015
Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade GliomaMichelle M Kim, Theodore S Lawrence, Yue CaoCancer Journal (Sudbury, Mass.)|October 5, 2023
Evolution of Response-Based Radiotherapy for Hepatocellular CancerAmeer L Elaimy, Yue Cao, Theodore S LawrenceSeminars in Radiation Oncology|May 26, 2009
Functional and metabolic magnetic resonance imaging and positron emission tomography for tumor volume definition in high-grade gliomasChristina I Tsien, Yue Cao, Theodore S LawrenceSeminars in Radiation Oncology|January 10, 2003
The mechanism of action of radiosensitization of conventional chemotherapeutic agentsTheodore S Lawrence, A William Blackstock, Cornelius McGinnRadiation Research|February 13, 2002
Wild-type TP53 inhibits G(2)-phase checkpoint abrogation and radiosensitization induced by PD0166285, a WEE1 kinase inhibitorJun Li, Yuli Wang, Yi Sun, et al.International Journal of Radiation Oncology, Biology, Physics|October 14, 2008
Radiation increases invasion of gene-modified mesenchymal stem cells into tumorsSteven P Zielske, Donna L Livant, Theodore S LawrenceTranslational Oncology|June 22, 2010
Loss of tumor-initiating cell activity in cyclophosphamide-treated breast xenograftsSteven P Zielske, Aaron C Spalding, Theodore S LawrenceCancer|September 5, 2002
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancerCornelius J McGinn, Theodore S Lawrence, Mark M ZalupskiPageof 55